We're at #PEGSBoston this week! Meet the team at Booth 214 to discuss our cutting-edge antibody discovery and development capabilities. From immune library generation and antibody optimisation to in silico modelling and characterisation, we're here to accelerate your research.

Dr. David Mosedale from RxCelerate will be a guest speaker at our #ScientificConference on 25 June. Don't miss his presentation discussing his work surrounding patients with Crohn's Disease. Reserve your spot now: registration.crowdcomms.com/bioresource2025

Less than a month to go until #BIO2025! We're co-exhibitors on the UK Pavilion (Stand 765, Hall A), organised by Department for Business and Trade to showcase the strength and innovation of the UK’s #lifesciences sector. Arrange to meet us via the BIO partnering app or email [email protected]

Meet our chemists at #ANMC2025 this week, sharing how our small molecule drug design and development approach can add significant value to your programme. Visit Booth 13 or contact: [email protected]

We're exhibiting on the UK Pavilion (Hall A, Stand 765) at #BIO2025. Use the BIO Business Partnering System to book a meeting with us if you need #outsourced drug discovery & development support.

A great week so far at #BIO2025 in #Boston Interesting conversations, new connections and a real buzz around the UK Pavilion! Meet us there (Stand 765) to talk about accelerating your drug discovery and development plans. Connect via the partnering app or [email protected]

Our CEO Jill is attending #ABI25 in Cambridge MA this week. The invite-only event brings together leaders from across #lifesciences to share ideas and create new partnerships. Find Jill to learn more about how RxCelerate supports innovative #drugdiscovery programmes.

We’re pleased to share a testimonial from Valent BioSciences, based in the US, following their successful use of our proprietary protein engineering technology. It is great to see our collaborative approach and expertise delivering results for our clients. 🔗rxcelerate.com/in-silico/

We've been shortlisted in the 2025 Business Weekly Awards! Thrilled to be recognised alongside some exceptional companies driving innovation across the Cambridge ecosystem. Congratulations to all those nominated. Read more: businessweekly.co.uk/posts/shortlis… #BusinessWeeklyAwards

We’re finalists in the Cambridge Independent Business Awards! We are proud to be shortlisted for Employer of the Year. It reflects the incredible effort so many people across the business put into making RxCelerate a supportive and rewarding place to work. 🔗cambridgeindependent.co.uk/business/final…

This morning, $CNTA announced business highlights and financial results for Q2FY25. You can see a brief summary below, and find the full release on our website at: investors.centessa.com/news-releases/…

We're a finalist for ‘Most Impactful CRO of the Year’ at OBN_UK's Awards Thank you for this recognition - named alongside many outstanding companies driving innovation across life sciences to improve patient outcomes. The finalists 👉obn.glueup.com/event/obn-awar…

Day 1 of #CamMedChem25 is underway! Find out how our extensive experience designing and delivering bespoke small molecule discovery programmes can accelerate your timeline-without shortcuts or compromise-just a focus on the right science. Meet Andy and Andrew at Booth 17.

It’s been great connecting with peers ELRIG Visit Stand F13 to find out how our flexible, science-led approach can support your next programme Or visit our posters no's 252 & 283, highlighting recent innovations from our in silico and preclinical teams #ELRIGDD25

Happy Halloween!

Find us at Booth C170 at #BIOEurope today! Our tailored approach to drug discovery and development means we can efficiently and successfully advance your assets - by leveraging our proprietary technologies, in-house expertise and state of the art facilities.

RxCelerate and Constructive Bio Announce Partnership to Advance Next-Generation Therapeutics ConstructiveBio's pioneering programmable biology platform combined with our expert drug design & development capabilities to transform biologic drug development rxcelerate.com/rxcelerate-and…